Boniva Tablets and Didanosine Tablet, for suspension
Determining the interaction of Boniva Tablets and Didanosine Tablet, for suspension and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Consumer information for this interaction is not currently available.ADJUST DOSING INTERVAL: Products containing aluminum, calcium, magnesium and other polyvalent cations such as antacids or vitamin with mineral supplements are likely to interfere with the gastrointestinal absorption of oral bisphosphonates. For example, the bioavailability of tiludronate has been shown to decrease 80% during simultaneous administration with calcium, and 60% when aluminum- or magnesium-containing antacids were administered one hour before tiludronate. MANAGEMENT: Antacids or other oral medications containing aluminum, calcium, magnesium and other polyvalent cations should be administered at least 30 minutes after the bisphosphonate dose. References Darcy PF "Nutrient-drug interactions." Adverse Drug React Toxicol Rev 14 (1995): 233-54 "Product Information. Boniva (ibandronate)." Roche Laboratories, Nutley, NJ. "Product Information. Skelid (tilundronate)." Sanofi Winthrop Pharmaceuticals, New York, NY. "Product Information. Bonefos (clodronate)." Rhone-Poulenc Rorer Canada Inc, Laval, QC. "Product Information. Actonel (risedronate)." Procter and Gamble Pharmaceuticals, Cincinnati, OH. "Product Information. Fosamax (alendronate)." Merck & Co, Inc, West Point, PA. View all 6 references
Professional:ADJUST DOSING INTERVAL: Products containing aluminum, calcium, magnesium and other polyvalent cations such as antacids or vitamin with mineral supplements are likely to interfere with the gastrointestinal absorption of oral bisphosphonates. For example, the bioavailability of tiludronate has been shown to decrease 80% during simultaneous administration with calcium, and 60% when aluminum- or magnesium-containing antacids were administered one hour before tiludronate.
MANAGEMENT: Antacids or other oral medications containing aluminum, calcium, magnesium and other polyvalent cations should be administered at least 30 minutes after the bisphosphonate dose.
- Darcy PF "Nutrient-drug interactions." Adverse Drug React Toxicol Rev 14 (1995): 233-54
- "Product Information. Boniva (ibandronate)." Roche Laboratories, Nutley, NJ.
- "Product Information. Skelid (tilundronate)." Sanofi Winthrop Pharmaceuticals, New York, NY.
- "Product Information. Bonefos (clodronate)." Rhone-Poulenc Rorer Canada Inc, Laval, QC.
- "Product Information. Actonel (risedronate)." Procter and Gamble Pharmaceuticals, Cincinnati, OH.
- "Product Information. Fosamax (alendronate)." Merck & Co, Inc, West Point, PA.
Generic Name: ibandronate
Brand name: Boniva, Bondronat
Synonyms: Ibandronate (oral/injection), Ibandronate
Generic Name: didanosine
Brand name: Videx, Videx EC
Synonyms: Didanosine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Boniva Tablets-Didrex
- Boniva Tablets-Didronel
- Boniva Tablets-Dienogest and estradiol
- Boniva Tablets-Diethylene Triamine Penta-Acetic Acid
- Boniva Tablets-Diethylpropion
- Boniva Tablets-Diethylpropion Controlled-Release Tablets
- Didanosine Tablet, for suspension-Bonjesta
- Didanosine Tablet, for suspension-Bontril
- Didanosine Tablet, for suspension-Bontril PDM
- Didanosine Tablet, for suspension-Bontril Slow-Release
- Didanosine Tablet, for suspension-Bontril Slow-Release Capsules
- Didanosine Tablet, for suspension-Boostrix